The STem Cell-derived Extracellular Vesicle Therapy In Acute Ischemic Stroke (STEVIA)

计划入组 18 人 · 首次发布于 2025 年 5 月 29 日

Patient-Derived Breast Cancer Organoids for Therapeutic Extracellular Vesicle Isolation (PDO-Mercurial01)

计划入组 50 人 · 首次发布于 2026 年 2 月 19 日

FoxBioNet: ECV (Extracellular Vesicle) 004

计划入组 140 人 · 首次发布于 2020 年 10 月 26 日

extracellular vesicle therapy (stroke)

Stem-cell derived exosome vesicle products

extracellular vesicle therapy (orthopedic conditions)

Lifecore Biomedical

United States

MiMedx

United States

Kamada

Israel

STRM.BIO Secures $8.4M ARPA-H Contract to Develop Novel Extracellular Vesicle Platform for In Vivo CAR-T Cell Engineering

Ginkgo Bioworks Partners with STRM.BIO and UBC to Develop In Vivo CAR Therapies for Autoimmune Diseases Under ARPA-H Program

Global Analysis Reveals Critical Dosing Gaps in MSC-Derived Extracellular Vesicle Clinical Trials